Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

AI-based analysis reveals novel blood protein biomarkers for predicting cardiac amyloidosis approximately a decade early: A UK biobank study

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJoshua FieggenKRKarthik RamasamyAWAshutosh Wechalekar

Discussion

Loading...

Member takes

Overview

AI-based analysis uncovers biomarkers predicting disease risk in amyloidosis, suggesting early clinical utility.

Key Points

  • Novel biomarkers predicted cardiac amyloidosis about a decade prior to diagnosis, supporting better early intervention.
  • The time-to-event prediction model achieved a strong concordance index of 0.81 on test data, showcasing its predictive capabilities.
  • Analysis utilized advanced multi-faceted statistical and machine learning approaches on the UK Biobank's extensive proteomics dataset.
  • Validation of these protein biomarkers is critical for understanding their role in various amyloidosis subtypes and future patient outcomes.

Cite This Study

Fieggen et al. (2025) studied this question.

synapsesocial.com/papers/69362f514fa91c937236d92dhttps://doi.org/10.1182/blood-2025-580
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement2025 · 3 citations
  2. 2Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement2025 · 1 citations
  3. 3Pre-diagnostic biomarkers show disease susceptibility continuum and enable early prediction of multiple myeloma2025 · 1 citations
  4. 4Proteomic profiling of amyloid deposits in advanced systemic light-chain (AL) amyloidosis: Insights into clonal light chains, chaperone proteins, and cardiac involvement2025
  5. 5Discovery-Driven Plasma Proteomics Identifies a Multi-Protein Signature for Amyloid PET Positivity: A Machine Learning Analysis of the Bio-Hermes Cohort2026